SEC Form 4 · accession 0001225208-16-037663
Edwards Lifesciences Corp · EW
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Huimin Wang
Officer — CVP, Japan & Intercontinental
Period of report
Aug 5, 2016
Accepted (ET)
Aug 9, 2016 · 6:20 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001099800
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2 | Aug 5, 2016 | M | 7,650 | $25.48 | A | 83,442 | D | |
| Common StockF3 | Aug 5, 2016 | M | 6,000 | $44.615 | A | 89,442 | D | |
| Common StockF3 | Aug 5, 2016 | S | 13,650 | $113.03 | D | 75,792 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Acquire)F3 | $44.615 | Aug 5, 2016 | M | 6,000 | D | May 12, 2012 | May 11, 2018 | Common Stock | 6,000 | 54,600 | D |
| Employee Stock Option (Right to Acquire)F3 | $25.48 | Aug 5, 2016 | M | 7,650 | D | May 13, 2011 | May 12, 2017 | Common Stock | 7,650 | 0 | D |
Explanation of responses
- F1The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 30, 2015.
- F2This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person. This amount includes quarterly acquisition of shares under the Edwards Lifesciences Corporation Employee Stock Purchase Plan as reflected on the most recent report of the plan administrator.
- F3This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person.